Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature.

ABSTRACT:

Introduction

Pharmacological therapy is recommended as a second-line alternative to reverse obesity. Currently, five anti-obesity drugs (AODs) have been approved by the U.S. Food and Drug Administration (FDA) for chronic weight management. The aim of this paper is to investigate the pharmacoeconomic evaluation of AODs through a systematic review with a special focus on methodological considerations.

Methods

We searched the general and specific databases to identify the primary pharmacoeconomic evaluation of AODs.

Results

A total of 18 full-text articles and three conference abstracts were included in this review. Most of the economic assessments were still about Orlistat. And the observations we could make were consistent with the previous systematic review. A few stu

SUBMITTER: Xue Y 

PROVIDER: S-EPMC10658190 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature